SWK Holdings Corp/ US78501P2039 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
3/21
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
GlobeNewswire
1/2
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
GlobeNewswire
3/7/2022
Acer Therapeutics Secures up to $48.5 Million in Convertible Note and Secured Loan Financing Facilit...
GlobeNewswire
1/18/2022
SWK HOLDINGS (SWKH) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating SWK Holdings Corpora...
GlobeNewswire
4/20/2021
Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026
GlobeNewswire
4/15/2021
Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026
GlobeNewswire
4/14/2021
Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jone...
GlobeNewswire
3/4/2021
EyePoint Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights ...
GlobeNewswire
1/11/2021
EyePoint Pharmaceuticals Provides Business Update and Preliminary Fourth Quarter and Full-Year 2020 ...
GlobeNewswire
12/18/2020
EyePoint Pharmaceuticals Announces $16.5 Million Monetization of ILUVIEN® Royalty with SWK Holdings ...
GlobeNewswire
9/21/2020
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
GlobeNewswire
9/21/2020
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
GlobeNewswire
9/17/2020
Onxeo Reports its Financial Results for the First Half of 2020 and Provides an Update on its Activit...
GlobeNewswire
9/14/2020
Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020
GlobeNewswire
9/14/2020
Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020
GlobeNewswire
6/29/2020
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
GlobeNewswire
4/6/2020
Onxeo to Receive $6.6 Million by Granting Additional Exclusive Rights to Belinostat to Acrotech Biop...
GlobeNewswire
3/27/2020
Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug Alkindi®...
GlobeNewswire
11/14/2019
Eton Pharmaceuticals Announces Third Quarter Financial Results and Highlights Business Progress